ClinicalTrials.govpublic full text
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
relapse b acute lymphoblastic leukemia, refactory childhood acute lymphoblastic leukemia, car t cell, cd19, il-7 receptor alpha, chimeric antigen receptor t cell, adoptive cellular therapy, b-cell acute lymphoblastic leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 827994
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.